Anchiano Therapeutics (ANCN) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ANCN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Anchiano Therapeutics Short Interest DataCurrent Short Volume65,200 sharesPrevious Short Volume190,200 sharesChange Vs. Previous Month-65.72%Dollar Volume Sold Short$231,460.00Short Interest Ratio / Days to Cover0.0Last Record DateFebruary 26, 2021Outstanding Shares7,420,000 sharesPercentage of Shares Shorted0.88%Today's Trading Volume3,373 sharesAverage Trading Volume3,145,648 sharesToday's Volume Vs. Average0% Short Selling Anchiano Therapeutics ? Sign up to receive the latest short interest report for Anchiano Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatANCN Short Interest Over TimeANCN Days to Cover Over TimeANCN Percentage of Float Shorted Over Time Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Anchiano Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/26/202165,200 shares $231,460.00 -65.7%N/A0 $3.55 2/12/2021190,200 shares $914,862.00 +2,370.1%N/A0.1 $4.81 1/29/20217,700 shares $16,697.45 -84.0%N/A0 $2.17 1/15/202148,200 shares $112,788.00 +18.1%N/A0 $2.34 12/31/202040,800 shares $79,560.00 +112.5%N/A0 $1.95 12/15/202019,200 shares $29,568.00 +910.5%N/A0 $1.54 Get the Latest News and Ratings for ANCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anchiano Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20201,900 shares $2,926.00 -84.7%N/A0 $1.54 11/15/202012,400 shares $17,484.00 -79.4%N/A0 $1.41 10/30/202060,100 shares $71,519.00 +526.0%N/A0.1 $1.19 10/15/20209,600 shares $11,136.00 -57.3%N/A0 $1.16 9/30/202022,500 shares $25,650.00 +97.4%N/A0.2 $1.14 9/15/202011,400 shares $12,198.00 +35.7%N/A0.1 $1.07 8/31/20208,400 shares $8,220.24 -56.0%N/A0.1 $0.98 8/14/202019,100 shares $22,156.00 +76.9%N/A0.2 $1.16 7/31/202010,800 shares $10,445.76 -49.3%N/A0.1 $0.97 7/15/202021,300 shares $16,658.73 +19.7%N/A0.2 $0.78 6/30/202017,800 shares $24,208.00 +24.5%N/A0.3 $1.36 6/15/202014,300 shares $21,650.20 +186.0%N/A0.2 $1.51 5/29/20205,000 shares $5,500.00 +42.9%N/A0.1 $1.10 5/15/20203,500 shares $3,273.90 -75.7%N/A0.1 $0.94 4/30/202014,400 shares $12,960.00 +2.9%N/A0.5 $0.90 4/15/202014,000 shares $10,918.60 +3.7%N/A0.6 $0.78 3/31/202013,500 shares $10,611.00 +62.7%N/A0.4 $0.79 3/13/20208,300 shares $7,286.57 -20.2%N/A0.6 $0.88 2/28/202010,400 shares $9,344.40 -21.8%N/A0.3 $0.90 2/14/202013,300 shares $11,837.00 -8.3%N/A0.4 $0.89 1/31/202014,500 shares $14,645.00 +202.1%N/A0.4 $1.01 1/15/20204,800 shares $6,144.00 -40.7%N/A0.1 $1.28 12/31/20198,100 shares $11,583.00 +14.1%N/A0.2 $1.43 ANCN Short Interest - Frequently Asked Questions What is Anchiano Therapeutics' current short interest? Short interest is the volume of Anchiano Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 26th, traders have sold 65,200 shares of ANCN short. Learn More on Anchiano Therapeutics' current short interest. Is Anchiano Therapeutics' short interest increasing or decreasing? Anchiano Therapeutics saw a drop in short interest in February. As of February 26th, there was short interest totaling 65,200 shares, a drop of 65.7% from the previous total of 190,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Anchiano Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Anchiano Therapeutics: PaxMedica, Inc. (2.12%), Petros Pharmaceuticals, Inc. (3.57%), Soligenix, Inc. (1.10%), Kazia Therapeutics Limited (1.59%), Bright Minds Biosciences Inc. (2.58%), Synaptogenix, Inc. (1.09%), Ensysce Biosciences, Inc. (0.60%), LumiraDx Limited (2.89%), GT Biopharma, Inc. (0.71%), Sonnet BioTherapeutics Holdings, Inc. (16.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($5.72 billion), Analog Devices, Inc. ($5.42 billion), Charter Communications, Inc. ($4.94 billion), Snap Inc. ($3.85 billion), Airbnb, Inc. ($2.46 billion), Warner Bros. Discovery, Inc. ($2.34 billion), Futu Holdings Limited ($2.31 billion), The Kroger Co. ($2.05 billion), Palo Alto Networks, Inc. ($1.89 billion), and Marathon Petroleum Co. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Anchiano Therapeutics stock? Short selling ANCN is an investing strategy that aims to generate trading profit from Anchiano Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anchiano Therapeutics? A short squeeze for Anchiano Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANCN, which in turn drives the price of the stock up even further. How often is Anchiano Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANCN, twice per month. The most recent reporting period available is February, 26 2021. More Short Interest Resources from MarketBeat Related Companies: PXMD Short Interest Data PTPI Short Interest Data SNGX Short Interest Data KZIA Short Interest Data DRUG Short Interest Data SNPX Short Interest Data ENSC Short Interest Data LMDX Short Interest Data GTBP Short Interest Data SONN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANCN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing